RT Book, Section
A1 Reznik, Scott I.
A1 Smythe, W. Roy
A2 Grippi, Michael A.
A2 Elias, Jack A.
A2 Fishman, Jay A.
A2 Kotloff, Robert M.
A2 Pack, Allan I.
A2 Senior, Robert M.
A2 Siegel, Mark D.
SR Print(0)
ID 1122367439
T1 Treatment of Non–Small-Cell Lung Cancer: Surgery
T2 Fishman's Pulmonary Diseases and Disorders, 5e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-179672-9
LK accessmedicine.mhmedical.com/content.aspx?aid=1122367439
RD 2024/04/19
AB Lung  cancer  represents  the  most  common  cause  of  cancer-related  death  in  the  world.  It  was  considered  a  rare  disease  until  the  early  part  of  the  20th  century.  In  1879,  lung  cancer  represented  only  1%  of  cancers  identified  at  autopsy  compared  to  14%  in  1927.1  The  famous  surgeon,  Alton  Oschner  reported  that  as  a  medical  student  in  1910,  he  was  called  to  the  autopsy  suite  to  see  a  case  of  lung  cancer,  since  it  was  so  rare  he  was  likely  to  never  see  another  case.  Seventeen  years  passed  before  he  saw  another  case  of  lung  cancer  and  then  he  saw  8  cases  in  6  months.2  The  link  between  tobacco  use  and  lung  cancer  has  been  common  knowledge  since  the  surgeon  general's  report  in  1964,  and  despite  that  knowledge,  the  death  rate  continued  to  rise  in  men  until  1991  and  in  women  until  2003.  The  treatment  of  lung  cancer  has  evolved  from  a  single  modality,  surgery,  to  a  multimodality  approach  that  calls  upon  the  skills  of  numerous  specialists.  Physicians,  who  diagnose  and  treat  lung  cancer,  must  work  together  to  define  the  role  that  surgery  plays  in  the  modern  management  of  lung  cancer.  Surgery,  when  appropriate  remains  the  cornerstone  of  therapy,  and  surgeons  play  an  integral  role  in  the  diagnosis  and  treatment  of  patients  with  lung  cancer.